[Treatment of intestinal dysbacteriosis in children with diabetes mellitus].
The use of the probiotic Acylact in combination with Viferone containing human recombinant interferon-alpha 2 in the treatment of intestinal dysbacteriosis in children with insulin-dependent diabetes mellitus (IDDM) was shown to be highly efficient. Elimination of microecologic disorders in the intestine was accompanied in all the children by immune rearrangements. The quantity of secretory and serum immunoglobulins and complement increased and the white blood cell chemiluminescence proved to be higher. The correction of the immune status of the children with IDDM resulted in a certain decrease of glycemia. The data are indicative of the fact that such a treatment of intestinal dysbacteriosis in children with IDDM is promising.
Voronin
A A
AA
Chair of Microbiology and Clinical Chemotherapy, Russian Academy of Postgraduate Medical Training, Moscow.
Taranenko
L A
LA
Sidorenko
S V
SV
D000293:Adolescent; D001424:Bacterial Infections / Q000150:complications / Q000188:drug therapy* / Q000276:immunology; D002648:Child; D002675:Child, Preschool; D003922:Diabetes Mellitus, Type 1 / Q000150:complications / Q000276:immunology*; D004359:Drug Therapy, Combination; D006801:Humans; D007107:Immune System / Q000187:drug effects; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000008:administration & dosage / Q000627:therapeutic use*; D007410:Intestinal Diseases / Q000150:complications / Q000188:drug therapy* / Q000276:immunology; D007778:Lactobacillus / Q000737:chemistry*; D019936:Probiotics / Q000737:chemistry / Q000627:therapeutic use*; D011994:Recombinant Proteins
D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins
Lechenie disbakterioza kishechnika u deteĭ, bol'nykh sakharnykh diabetom.